How to find, recruit and maintain rare blood donors

Current Opinion in Hematology

Volumn 16, Issue 6, 2009, Pages 503-508

  Nance, Sandra Taddie ^a,b,c,d  

^a AMERICAN RED CROSS   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c American Rare Donor Program   (United States)

^d Working Party for Rare Donors   (Netherlands)

Author keywords

Rare blood; Rare blood type; Rare donor; Red cell type

Indexed keywords

BLOOD DONOR; BLOOD GROUP TYPING; BLOOD TRANSFUSION; HEALTH PROGRAM; HUMAN; PERSUASIVE COMMUNICATION; PRIORITY JOURNAL; REVIEW; VOLUNTEER; DONOR SELECTION;

BLOOD GROUP ANTIGEN;

BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; DONOR SELECTION; HUMANS;

EID: 73949122749     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283316bed     Document Type: Review

References (41)

1. Mourant AE. The establishment of an international panel of donors of rare types. Vox Sang 1965; 10:129-132.
2. Anstee D, Levene C, Mallory D, et al. Rare Blood, an ISBT Working Party Report on Rare Blood Donors. Vox Sang 1999; 77:58-62. (Pubitemid 29408269)
3. Woodfield G, Poole J,Nance ST, Daniels G. A review of the ISBT rare blood donor program. Immunohematology 2004; 20:244-248.
4. Mallory D, Malamut D, Sandler SG. A decade of rare donor services in the United States. Vox Sang 1992; 63:186-191.
5. Yahalom V, Shinar E, Poole J, et al. The rare donor registry In Israel. Vox Sang 2002; 83:29.
6. Peyrard T, Fialaire-Legendre A, Noizat-Plrenne F. A national file of Individuals presenting a rare phenotype and a national blood bank for rare blood units: a five year experience. Transfusion 2006; 46:132A.
7. Flickinger C, Petrone T, Church A. Review: American Rare Donor Program. Immunohematology 2004; 20:239-243.
8. Beattie KM, Shafer AW. Broadening the base of a rare donor program by targeting minority populations. Transfusion 1986; 26:401-404.
9. Price CL, Boyd JH, Watkins AR, et al. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion 2006; 46:1388-1393.
10. Titmuss RM. The gift relationship: from human blood to social policy. London: George Allan and Unwin Ltd.; 1970.
11. Ottong JG, Asuquo EEJ, Olaniran NS, et al. Community mobilization for blood donation, Cross River State, Nigeria. Int J Gynecol Obstet 1997; 59:S119S125.
12. Sandborg E. Getting people to give blood. Vox Sang 2000; 78:297-301.
13. Glynn SA, Kleinman SH, Schreiber GB, et al. Motivations to donate blood: demographic comparisons. Transfusion 2002; 42:216-225.
14. Boulware LE, Ratner LE, Ness PM, et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 2002; 42:669-678.
15. Olalya MA, Alaklja W, Ajala A, Olatunji RO. Knowledge, attitudes, beliefs and motivations towards blood donations among blood donors in Lagos, Nigeria. Transfus Med 2004; 14:13-17.
16. Levene C, Asher O, Shinar E, Yahalom V. Rare blood donors: a personal approach. Immunohematology 2006; 22:64-68. (Pubitemid 44087155)
17. Seltsam A, Wagner FF, Salama A, Flegel W. Antibodies to high frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003; 43:1563-1566. (Pubitemid 37371827)
18. Kormoczi GF, Wagner T, Jungbauer C, et al. Genetic diversity of KELnull and KELeI: a nationwide Austrian survey. Transfusion 2007; 47:703-714.
19. Yang BC, Su YQ, Yu Q, et al. Molecular genetic analysis of Diego blood group Dia and Dib in Chinese Han population. Fa Yi Xue Za Zhi 2007; 23:283-285.
20. Hashimi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007; 47:736-747.
21. Polin H, Danzer M, Proll J, et al. Introduction of a real-time based blood group genotyping approach. Vox Sang 2008; 95:125-130. (Pubitemid 351951895)
22. Wagner FF, Bittner R, Petershofen EK, et al. Cost-efficient sequence specific priming-polymerase chain reaction screening for blood donors with rare phenotypes. Transfusion 2008; 48:1169-1173.
23. Avent ND, Martinez A, Flegel WA, et al. The BloodGen project: towards massscale comprehensive genotyplng of blood donors In the European Union and beyond. Transfusion 2007; 47 (Suppl):40S-48S.
24. Avent ND. Large-scale blood group genotyplng: clinical implications. Br J Hematol 2008; 144:3-13.
25. Karpasitou K, Drago F, Crespiatico L, et al. Blood group genotyping for Jk(a)/ Jk(b), Fy(a)/Fy(b), S/s, K/k, Js(a)/Js(b), Co(a)/Co(b), and Lu(a)/Lu(b) with microarray beads. Transfusion 2008; 48:505-512.
26. B- phenotype In black persons. Transfusion (in press).
27. Grassineau D Papa K Ducourneau A, et al. Improving minority blood donation: anthropologic approach In a migrant community. Transfusion 2007; 47:402-409.
28. Schmidt AH, Stahr A, Baler D, et al. Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes. Bone Marrow Transplant 2007; 40:823-830.
29. Price CL, Johnson MT, Lindsay T, et al. The sickle cell Sabbath: a community program Increases first time blood donors in the African American faith community. Transfusion 2009; 49:519-523.
30. Nance SJ. ISBT Working Party for Rare Donors. Transfus Today 2007; 71:15.
31. Nance SJ. ISBT Working Party for Rare Donors: 24 years of international collaboration. Transfus Today 2008; 75:4-11.
32. Nance SJ. The utilization of rare blood donors. ISBT Sci Ser 2007; 2:59-63.
33. Peyrard T, Pham BN, Le Penneo PY, Rouger P. The rare blood groups: a public health challenge. Transfus Clin Biol 2008; 15:109-119.
34. Flegel WA, Von Zabern I, Kroll H, Just B. Rare blood utilization during a 2.5 years observation period in Germany. Vox Sang 2008; 95 (Suppl):114.
35. Marconi M, Revelli N, Villa MA, et al. A regional rare blood donor registry and bank of frozen blood units In Italy. Transfus Today 2008; 76:25.
36. Dake L. Rare blood challenges blood bank and patients. MLO Med Lab Obs 2007; 39:34-36.
37. Reesink HW, Engelfriet CP, Schennach H, et al. Donors with a rare pheno (geno) type. Vox Sang 2008; 95:236-253.
38. Redman M, Regan F, Contreras M. A prospective study of the Incidence of red cell allo-immunization following transfusion. Vox Sang 1996; 71:215-220.
39. Sohoneville H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127-1131.
40. Garratty G. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion. Vox Sang 2007; 94:87-95.
41. Bagnis C, Chapel S, Chiaroni J, Bailly P. A genetic strategy to control expression of human blood group antigens In red blood cells generated In vitro. Transfusion (in press).